Work

Phase II trial of temsirolimus in patients with metastatic breast cancer

Year: 2012

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-011-1910-7

Authors: Gini F. Fleming, Cynthia X. Ma, Dezheng Huo, Husain Sattar, Maria Tretiakova, L. Lin, Olwen M. Hahn, F. O. Olopade, R. Nanda, Philip C. Hoffman, M. J. Naughton, Timothy Pluard, Suzanne D. Conzen, Matthew J. Ellis

Institutions: University of Chicago Medical Center, Washington University in St. Louis

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1901730563, G4389241953, SPORE in Breast Cancer, Cancer Center Support Grant

OpenAlex ID: W1976559692

FWCI: 3.252

Cites: 36

Cited by: 77

Related to: 10